VCEL FY 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$64M+17.5% YoY

Gross Profit

$34M52.5% margin

Operating Income

-$15M-23.4% margin

Net Income

-$17M-27.0% margin

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$55M

Total Liabilities

$32M

Stockholders' Equity

$23M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$54M	+17.5%
Gross Profit	$34M	$26M	+28.7%
Operating Income	-$15M	-$19M	+22.1%
Net Income	-$17M	-$20M	+11.7%